Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05251428
Other study ID # STUDY00003754
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 30, 2023
Est. completion date December 2027

Study information

Verified date March 2024
Source Emory University
Contact Eric Wagner, MD, MS
Phone 404-778-7249
Email eric.r.wagner@emory.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Trigger finger is a common condition of the hand caused by the thickening of the A1 pulley or flexor tendon that alters the way in which the flexor tendon glides within the tendon sheath. The purpose of this study is to evaluate the efficacy of excision versus incision of the A1 pulley for the trigger finger. Researchers hypothesize that excision of the A1 pulley would result in lower trigger finger recurrence rates, better pain relief, reduced soreness & stiffness as well as higher final Patient-Reported Outcomes Measurement (PROMs). This will be investigated via a randomized controlled study involving patients randomized in either of the aforementioned surgical treatment groups, which are both standards of care, at the Musculoskeletal Institute or at the Emory University Orthopaedic and Spine Hospital. Patients will then follow up in the clinic at 2 weeks, 6 weeks, 3 months, 6 months, and 1 year to assess their outcomes measures stated in the protocol document. All work related to this project will take place at the Emory Sports Medicine Complex, Emory Executive Park, Emory Musculoskeletal Institute, and the Emory University Orthopaedic and Spine Hospital. Patients will not be compensated for participating in this study. Patients who are undergoing trigger finger surgery will be identified by their Orthopaedic surgeon who is a member of the study team. The surgeon will briefly discuss participation with the patient and make clear study expectations.


Description:

Trigger finger is a common condition of the hand that affects up to 2.6% of the adult population over the course of their lifetimes. This prevalence is even higher in patients with diabetes affecting 5-20% of people. The condition is caused by the thickening of the A1 pulley or flexor tendon that alters the way in which the flexor tendon glides within the tendon sheath. While first-line therapy for this condition is conservative treatment through activity modification, bracing, and corticosteroid injections, this fails a reported 20-50% of the time. In cases in which conservative management failure occurs, surgery is the next line of treatment. The purpose of this study is to evaluate the efficacy of excision versus incision of the A1 pulley for the trigger finger. The research team hypothesizes that excision of the A1 pulley would result in lower trigger finger recurrence rates, better pain relief, reduced soreness & stiffness as well as higher final PROMs. Surgery can be performed either percutaneously or open. Rates of persistent triggering in the percutaneous release group range from 7 to 9%. Additionally, even with open procedures, there is some risk of persistent triggering or symptom recurrence. A study by Everding et al. reported a recurrent triggering rate of 2.6% in their cohort of 795 patients who underwent open trigger finger release. A review of 209,634 patients who underwent trigger digit release from the PearlDiver Database reported a revision rate of 0.4% at 1 year and 0.64% at 3 years. Finally, a retrospective study by Bruijnzeel et al. demonstrated a 0.6% risk of persistent triggering and a 0.3% risk of recurrence in their sample of 1,598 patients. Risk factors for revision include Dupuytren's disease, rheumatoid arthritis, liver, disease, obesity, tobacco use, peripheral vascular disease, diabetes mellitus, and age under 65 years. In cases of recurrence, the procedure can be repeated to release any remaining portion of the A1 pulley, partial release of the A2, or release of the ulnar slip of flexor digitorum superficialis. Two biomechanical studies have demonstrated that the entire A1 pulley and up to 50% of the A2 pulley can be released with minimal risk for bowstringing. There have also been studies assessing the use of different incision types for open procedures and their effects on scar formation. Kazmers et al. compared scar formation from trigger finger release through a transverse skin incision versus a longitudinal incision and found no difference in DASH scores, complication rates, or scar quality metrics in the 61 patients studied. Additionally, a study comparing a transverse incision at the distal palmar crease, a transverse incision 2-3 mm distal to the distal palmar crease, and a longitudinal incision at the level of the A1 pulley demonstrated similar results between the longitudinal incision and the incision 2-3 mm distal to the distal palmar crease with no difference in scar volume as measured by ultrasound. There have been no studies to date assessing the effect of complete A1 pulley resection in comparison to longitudinal release of the A1 pulley. Theoretically, resection of the A1 pulley should reduce the rate of persistent triggering and recurrence and thus result in superior patient outcomes; however, this has yet to be determined.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date December 2027
Est. primary completion date February 2027
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age 18 or older - All patients undergoing surgery for trigger finger syndrome - Patients willing and able to provide informed consent Exclusion Criteria: - Adults unable to consent - Individuals who are not yet adults (infants, children, teenagers) - Pregnant women - Prisoners

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Excision of the A1 pulley
Participants will undergo excision of the A1 pulley. Wounds will then be irrigated and closed in the standard fashion.
Incision of the A1 pulley in the standard fashion
Participants will undergo incision of the A1 pulley in the standard fashion. Wounds will then be irrigated and closed in the standard fashion.

Locations

Country Name City State
United States 12 Executive Park Drive Atlanta Georgia
United States Emory at Dunwoody Atlanta Georgia
United States Emory Musculoskeletal Institute Atlanta Georgia
United States Emory Orthopaedics and Spine Center Atlanta Georgia
United States Emory Orthopedic and Spine Hospital Atlanta Georgia
United States Emory Saint Joseph's Hospital Atlanta Georgia

Sponsors (1)

Lead Sponsor Collaborator
Emory University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Change in the range of motion (ROM) Participants will be asked to complete questionnaires to evaluate their stiffness at each follow-up visit. The range of motion (ROM) will be measured using a finger goniometer ranging from 0 to 180 degrees. Additional hand function outcomes will be measured using the Disabilities of Arm, Shoulder, and Hand Questionnaire (DASH) which consists of subjectively rating the difficulty of a list of activities of daily living from 0-5 (0: no difficulty, 5=unable). Baseline, 2 weeks, 6 weeks, 3 months, 6 months, and 1 year
Other Change in patients' reported Working status The Upper Extremity Patient-Reported Outcomes Program (PROM) is a patient outcomes questionnaire that will be completed by the study participant at every visit. This questionnaire is administered electronically on a Microsoft tablet in the study room with the study participants' own password-secured profile log. The questionnaire consists of the subjective scores described above (DASH, VAS) as well as questions pertaining to current work status (unable to work, employed, caregiver/homemaker, retired). Baseline, 2 weeks, 6 weeks, 3 months, 6 months, and 1 year
Other Change in the pain score Participants will be asked to complete questionnaires to evaluate their pain at each follow-up visit. The Visual Analog Scale will be the subjective measurement to evaluate changes in pain scores, with values ranging from 0 (no pain) to 10 (very severe pain). A higher score indicates worse pain. Baseline, 2 weeks, 3 months, 6 months, and 1 year
Other Recurrent trigger finger after A1 pulley release The research team will assess participants for recurrence of their symptoms. Recurrence of the trigger finger is defined as finger triggering after the surgery. Finger triggering is described as the involved finger becoming stuck in a bent position and straightening with a snap, like a trigger being pulled and released. This is a clinical manifestation of the pathology, evaluated and determined by the treating surgeon. Baseline, 2 weeks, 6 weeks, 3 months, 6 months, and 1 year
Primary Change in the pain score Participants will be asked to complete questionnaires to evaluate their pain at each follow-up visit. The Visual Analog Scale will be the subjective measurement to evaluate changes in pain scores, with values ranging from 0 (no pain) to 10 (very severe pain). A higher score indicates worse pain. Baseline and 6 weeks
See also
  Status Clinical Trial Phase
Completed NCT04094389 - Comparison of Trigger Finger Orthotic Wearing Schedules N/A
Completed NCT05435950 - Clinical Investigation on Safety, Performance and Effectiveness of Sono-instruments N/A
Completed NCT04900220 - Differences in Flare Reaction Incidence and Intensity Following Trigger Finger Injections Phase 4
Completed NCT06401473 - Using the Gate Control Theory of Pain to Decrease Pain During Trigger Finger Corticosteroid Injections N/A
Completed NCT04354415 - Tourniquet vs. No Tourniquet for Carpal Tunnel and Trigger Finger Release N/A
Recruiting NCT06296017 - Effectiveness of Conservative Interventions in the Treatment of Trigger Finger N/A
Completed NCT06288685 - Percutaneous Trigger Finger Release Concomitant Steroid Injection Versus Percutaneous Trigger Finger Release Alone Phase 3
Completed NCT06382623 - Efficacies of Different Managements in Patients With Trigger Finger
Active, not recruiting NCT04568993 - The TriggerHappy Trial N/A
Completed NCT04023695 - Trigger Finger Corticosteroid Injection With and Without Local Anesthetic Phase 4
Recruiting NCT04645303 - Injection of Hyaluronic Acid Versus Corticosteroid for Treatment of Trigger Finger Early Phase 1
Recruiting NCT03156829 - Effectiveness of Cortisone Injection and Splinting for Trigger Finger Phase 4
Completed NCT01987115 - Comparison of Fascial Manipulation With Traditional Physiotherapy for the Treatment of Trigger Fingers N/A
Completed NCT02196233 - Surgical Treatment of Adult Trigger Finger
Completed NCT01950793 - A Comparison Between Sonoguided Injection Corticosteroid and Hyaluronic Acid Injection in Treatment of Trigger Finger N/A
Recruiting NCT04675892 - Resection of Flexor Digitorum Superficialis Tendon for Severe Trigger Fingers N/A
Terminated NCT05082480 - Evaluate the Effectiveness of Crosslinked HA on the Adhesion Preventing After Trigger Finger Release Surgery N/A
Recruiting NCT05045157 - Effectiveness of Percutaneous Pulley Release With Infiltration, Versus Infiltration Alone in Trigger Finders N/A
Active, not recruiting NCT01886157 - Treatment of Trigger Finger With Steroid Injection Versus Steroid Injection and Splinting N/A
Recruiting NCT00951236 - Study Comparing One Versus Two Cortisone Injections for Trigger Finger N/A